We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Bc6.0
BCAAs Research
Likely helps
229 peer-reviewed studies
What the evidence says
Probably helps
BCAAs helped in about half (2/3) of the studies that measured an effect — promising, but not unanimous.
Most evidence is from high-quality meta-analyses and randomised trials published 1979–2026 with a typical study size of 32 participants.
Based on 229 studies · 30 meta-analyses · 164 RCTs · 58,832 total participants
Confidence
High confidence
What the studies found
2helped1unclear· 226 more without graded effect data
By outcome
Therapeutic & clinical
Too few graded studies69 studies
Lean body mass & muscle growthMuscle protein synthesis support · Immediate to 2 hours
Too few graded studies39 studies
RecoveryReduced muscle soreness · 24-48 hours
Too few graded studies31 studies
Muscle strength & powerMuscle protein synthesis support · Immediate to 2 hours
Too few graded studies11 studies
Glucose & metabolic
Too few graded studies10 studies
Energy & fatigueReduces central fatigue during prolonged exercise · During exercise
Too few graded studies7 studies
Endurance & exercise performanceReduced mental fatigue during exercise · During exercise · Modest reduction in central fatigue during endurance work · Ongoing
Too few graded studies6 studies
Heart & blood pressure
Too few graded studies5 studies
Safety profile
Too few graded studies5 studies
Liver health
Too few graded studies1 study
By the numbers
Pulled from 32 studies with measurable effects
Likely real effects
100%
across studies
People studied
59k
typical study: 32 people
Strongest designs
194
30 pooled, 164 randomised
Showed benefit
67%
2/3 studies
How long studies ran
1–3 months
1
3+ months
4
Populations Studied
General population4
Old patients with sarcopenia1
Cirrhotic patients1
Prediabetes and diabetes patients1
Active research area
89 studies in the last 5 years · Latest meta-analysis: 2026
197920022026
1Sarcopenia treatment and mitochondrial functionSystematic ReviewCited 35×n=1,337 · large study2023
In plain English: BCAA alone (2 RCTs) or PUFA (1 RCT) were not effective in improving muscle health.
Cochet C et al. · Nutrients (2023)
Mitochondrial function was significantly improved by the administration of BCAA alone (1 RCT) or in association with vitamin D (1 RCT).
BCAA alone (2 RCTs) or PUFA (1 RCT) were not effective in improving muscle health.
In conclusion, BCAA in association with vitamin D may be useful in the treatment of sarcopenia and boost mitochondrial bioenergetic and redox activity.
2Event-free survival in cirrhotic patientsMeta-AnalysisCited 25×n=5,184 · very large study2023
In plain English: Prophylactic BCAA supplementation appears safe and might improve survival in cirrhotic patients.
van Dijk AM et al. · European journal of clinical investigation (2023)
Large benefit
← WorseNo effectBetter →
Likely real
Meta-analysis of 54 studies (34 randomised trials) in chronic liver disease: 2,308 patients given BCAA and 2,876 disease controls, with high or serious risk of bias in almost all studies.
Long-term (at least 6 months) BCAA in cirrhosis improved event-free survival (RR 0.61, 95% CI 0.42-0.88, p = .008) and tended to improve overall survival (RR 0.58, 95% CI 0.34-1.00, p = .05).
No convincing benefit on liver function, nutritional status or quality of life, and no study reported serious side effects.
3Cardiovascular disease riskMeta-AnalysisCited 32×n=43,895 · very large study2022
In plain English: Evidence suggests that elevated concentrations of circulating Isoleucine were associated with increased risks of CVD, independent of traditional risk factors.
Wang Y et al. · Atherosclerosis (2022)
Systematic review and meta-analysis of observational studies: 11 non-prospective studies (2,806 participants) and 10 prospective studies (43,895 participants) on circulating BCAA and cardiovascular disease.
In nine prospective studies, each SD higher isoleucine carried a 10% higher CVD risk (pooled RR 1.10, 95% CI 1.03-1.18), while valine and leucine were not associated with CVD overall.
In adults 60 or younger all three BCAAs were associated with higher risk, with no association in adults over 60. These are blood levels, not supplement trials.
4Type 2 diabetes risk per SD of circulating isoleucineMeta-AnalysisCited 746×n=8,000 · very large study2016
In plain English: In studies using high-throughput metabolomics, several blood amino acids appear to be consistently associated with the risk of developing type 2 diabetes.
Guasch-Ferré M et al. · Diabetes care (2016)
Systematic review of 46 cross-sectional and prospective metabolomics publications, with a meta-analysis of eight prospective studies in 8,000 people, 1,940 of whom had type 2 diabetes.
Each SD higher isoleucine, leucine and valine carried about 35-36% higher type 2 diabetes risk (isoleucine RR 1.36, 95% CI 1.24-1.48).
Glycine and glutamine were inversely associated with type 2 diabetes risk (RR 0.89 and 0.85). These are blood levels, not supplement trials.
In plain English: The contradictory effects of BCAAs on seizure activity likely reflect differences in the complex mechanisms that underlie seizure disorders.
Gruenbaum SE et al. · CNS drugs (2019)
The contradictory effects of BCAAs on seizure activity likely reflect differences in the complex mechanisms that underlie seizure disorders.
Some of these mechanisms are likely mediated by BCAA's effects on glucose, glutamate, glutamine, and ammonia metabolism, activation of the mechanistic target of rapamycin signaling pathway, and their effects on aromatic amino acid transport and neurotransmitter synthesis.
We propose that a better understanding of mechanisms by which BCAAs affect seizures and neuronal viability is needed to advance the field of BCAA supplementation in epilepsy.
In plain English: Further studies are warranted to confirm the effects of the supplements on football players, to identify the appropriate dosage of the supplements and also to determine their mechanism of action.
Allahyari P et al. · Journal of basic and clinical physiology and pharmacology (2025)
B vitamins reduce the level of blood lactate in the recovery periods.
Vitamin E and vitamin C may improve performance by decreasing oxidative stress and increasing the antioxidant capacity and oxygen delivery to exercising skeletal muscles.